Latest Shareholder Approvals News

Pilot Energy Limited has announced a substantial 58% increase in the carbon storage capacity of its Cliff Head project, alongside securing $6.3 million in capital and advancing a joint venture for Direct Air Capture technology.

Tambourah Metals reports significant high-grade gold assay results from its Pilbara projects and secures government grants to accelerate drilling programs across multiple prospects.

A1 Investments & Resources Ltd reported a $36,000 net cash outflow for the September quarter, maintaining a slim cash balance of $2,000. The company is actively pursuing acquisitions and plans to raise $300,000 through convertible notes, pending shareholder approval.

Tribune Resources Limited has announced an on-market buy-back of up to 5.25 million shares, signaling confidence in its capital structure and aiming to enhance shareholder value over the next year.

ReNu Energy reports progress on a management buyout proposal for its hydrogen subsidiary and completes sale of legacy geothermal assets, signaling a strategic pivot and ongoing capital challenges.

HITIQ Limited’s largest shareholder, Harmil Angel Investments, is converting $1.6 million in convertible notes into shares, while the company revamps its advisory mandate to attract US investors.

Group 6 Metals Limited reveals a challenging quarter marked by safety incidents and production setbacks at its Dolphin Tungsten Mine, while initiating a major recapitalisation plan to stabilise finances and leadership.

Accelerate Resources has successfully raised $1.35 million to accelerate exploration at its newly acquired Kanowna East Gold Project, marking a strategic push into the prolific Kalgoorlie gold region.

Nova Eye Medical Limited is raising A$6.6 million to strengthen its financial position following resolved supply chain disruptions, while reporting strong sales growth and nearing profitability in its glaucoma division.

Aurora Energy Metals has executed a landmark Option Agreement with Eagle Energy Metals for its flagship Aurora Uranium Project, unlocking up to US$26 million in share consideration and retaining significant exposure through a 40% equity stake. The company also reports improved uranium recovery rates and strategic expansion into Western Australia.

Nova Eye Medical has completed a $6.6 million placement to fund growth initiatives, supported by strong global sales growth and a major shareholder commitment. The capital raise aims to bolster sales teams and product development as the company targets profitability in its glaucoma division.

Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.